Milestone Scientific (MLSS) - Net Assets
Based on the latest financial reports, Milestone Scientific (MLSS) has net assets worth $2.55 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.49 Million) and total liabilities ($5.94 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check MLSS strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $2.55 Million |
| % of Total Assets | 30.04% |
| Annual Growth Rate | 1.36% |
| 5-Year Change | -63.79% |
| 10-Year Change | -36.36% |
| Growth Volatility | 204.56 |
Milestone Scientific - Net Assets Trend (1996–2024)
This chart illustrates how Milestone Scientific's net assets have evolved over time, based on quarterly financial data. For live market cap and overall valuation, see how much is Milestone Scientific worth.
Annual Net Assets for Milestone Scientific (1996–2024)
The table below shows the annual net assets of Milestone Scientific from 1996 to 2024. Also explore how fast is Milestone Scientific growing its equity to track the company's year-over-year net asset growth rate.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $5.83 Million | -27.21% |
| 2023-12-31 | $8.01 Million | -19.93% |
| 2022-12-31 | $10.01 Million | -38.29% |
| 2021-12-31 | $16.22 Million | +0.67% |
| 2020-12-31 | $16.11 Million | +888.98% |
| 2019-12-31 | $1.63 Million | +6.57% |
| 2018-12-31 | $1.53 Million | -79.63% |
| 2017-12-31 | $7.50 Million | -12.13% |
| 2016-12-31 | $8.54 Million | -6.86% |
| 2015-12-31 | $9.17 Million | -39.07% |
| 2014-12-31 | $15.04 Million | +172.51% |
| 2013-12-31 | $5.52 Million | +185.04% |
| 2012-12-31 | $1.94 Million | +0.01% |
| 2011-12-31 | $1.94 Million | -16.97% |
| 2010-12-31 | $2.33 Million | -11.70% |
| 2009-12-31 | $2.64 Million | +88.63% |
| 2008-12-31 | $1.40 Million | -8.98% |
| 2007-12-31 | $1.54 Million | -58.57% |
| 2006-12-31 | $3.71 Million | -41.23% |
| 2005-12-31 | $6.32 Million | +39.76% |
| 2004-12-31 | $4.52 Million | +284.92% |
| 2003-12-31 | $-2.44 Million | +59.96% |
| 2002-12-31 | $-6.11 Million | -36.94% |
| 2001-12-31 | $-4.46 Million | -161.93% |
| 2000-12-31 | $-1.70 Million | -179.94% |
| 1999-12-31 | $2.13 Million | -74.34% |
| 1998-12-31 | $8.30 Million | -55.14% |
| 1997-12-31 | $18.50 Million | +362.50% |
| 1996-12-31 | $4.00 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Milestone Scientific's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 12535310600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $78.05K | 1.34% |
| Other Components | $133.81 Million | 2294.10% |
| Total Equity | $5.83 Million | 100.00% |
Milestone Scientific Competitors by Market Cap
The table below lists competitors of Milestone Scientific ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Hansol Homedec
KO:025750
|
$20.76 Million |
|
Tainwala Chemical and Plastic (I) Limited
NSE:TAINWALCHM
|
$20.76 Million |
|
Performance Shipping Inc
NASDAQ:PSHG
|
$20.76 Million |
|
Penpower Technology Ltd
TWO:5211
|
$20.78 Million |
|
Fredonia Mining Inc
V:FRED
|
$20.75 Million |
|
Parlem Telecom Companyia de Telecomunicacions S.A.
MC:PAR
|
$20.75 Million |
|
Biofish Holding AS
OL:BFISH
|
$20.74 Million |
|
Only World Group Holdings Bhd
KLSE:5260
|
$20.74 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Milestone Scientific's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,012,511 to 5,832,700, a change of -2,179,811 (-27.2%).
- Net loss of 4,713,597 reduced equity.
- New share issuances of 192,156 increased equity.
- Other factors increased equity by 2,341,630.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-4.71 Million | -80.81% |
| Share Issuances | $192.16K | +3.29% |
| Other Changes | $2.34 Million | +40.15% |
| Total Change | $- | -27.21% |
Book Value vs Market Value Analysis
This analysis compares Milestone Scientific's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.24x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 0.14x to 5.24x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1996-12-31 | $2.72 | $0.38 | x |
| 1997-12-31 | $9.08 | $0.38 | x |
| 1998-12-31 | $2.84 | $0.38 | x |
| 1999-12-31 | $0.73 | $0.38 | x |
| 2000-12-31 | $-0.49 | $0.38 | x |
| 2001-12-31 | $-1.20 | $0.38 | x |
| 2002-12-31 | $-1.47 | $0.38 | x |
| 2003-12-31 | $-0.52 | $0.38 | x |
| 2004-12-31 | $0.49 | $0.38 | x |
| 2005-12-31 | $0.57 | $0.38 | x |
| 2006-12-31 | $0.31 | $0.38 | x |
| 2007-12-31 | $0.13 | $0.38 | x |
| 2008-12-31 | $0.11 | $0.38 | x |
| 2009-12-31 | $0.20 | $0.38 | x |
| 2010-12-31 | $0.16 | $0.38 | x |
| 2011-12-31 | $0.13 | $0.38 | x |
| 2012-12-31 | $0.12 | $0.38 | x |
| 2013-12-31 | $0.32 | $0.38 | x |
| 2014-12-31 | $0.73 | $0.38 | x |
| 2015-12-31 | $0.48 | $0.38 | x |
| 2016-12-31 | $0.32 | $0.38 | x |
| 2017-12-31 | $0.22 | $0.38 | x |
| 2018-12-31 | $0.04 | $0.38 | x |
| 2019-12-31 | $0.04 | $0.38 | x |
| 2020-12-31 | $0.26 | $0.38 | x |
| 2021-12-31 | $0.24 | $0.38 | x |
| 2022-12-31 | $0.14 | $0.38 | x |
| 2023-12-31 | $0.11 | $0.38 | x |
| 2024-12-31 | $0.07 | $0.38 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Milestone Scientific utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -80.81%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -54.62%
- • Asset Turnover: 0.88x
- • Equity Multiplier: 1.68x
- Recent ROE (-80.81%) is above the historical average (-91.92%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1996 | -47.50% | -633.33% | 0.06x | 1.18x | $-2.30 Million |
| 1997 | -40.00% | -255.17% | 0.15x | 1.08x | $-9.25 Million |
| 1998 | -128.92% | -121.59% | 0.96x | 1.11x | $-11.53 Million |
| 1999 | -327.40% | -244.17% | 0.51x | 2.64x | $-7.19 Million |
| 2000 | 0.00% | -132.35% | 2.22x | 0.00x | $-7.34 Million |
| 2001 | 0.00% | -97.51% | 2.70x | 0.00x | $-3.55 Million |
| 2002 | 0.00% | -59.90% | 3.28x | 0.00x | $-1.83 Million |
| 2003 | 0.00% | -60.75% | 2.31x | 0.00x | $-2.17 Million |
| 2004 | -66.29% | -63.08% | 0.88x | 1.19x | $-3.45 Million |
| 2005 | -43.59% | -42.81% | 0.91x | 1.12x | $-3.39 Million |
| 2006 | -84.89% | -53.94% | 1.14x | 1.38x | $-3.52 Million |
| 2007 | -191.03% | -45.98% | 1.28x | 3.24x | $-3.09 Million |
| 2008 | -84.81% | -17.93% | 1.50x | 3.15x | $-1.33 Million |
| 2009 | -57.93% | -17.90% | 1.76x | 1.84x | $-1.79 Million |
| 2010 | -26.35% | -6.30% | 1.48x | 2.83x | $-847.72K |
| 2011 | -76.54% | -17.69% | 1.20x | 3.61x | $-1.68 Million |
| 2012 | -44.94% | -10.06% | 1.53x | 2.92x | $-1.06 Million |
| 2013 | 26.54% | 14.63% | 1.24x | 1.46x | $912.95K |
| 2014 | -11.62% | -16.47% | 0.59x | 1.19x | $-3.17 Million |
| 2015 | -53.04% | -57.60% | 0.74x | 1.24x | $-6.50 Million |
| 2016 | -69.96% | -56.73% | 0.77x | 1.59x | $-6.80 Million |
| 2017 | -71.60% | -45.97% | 0.72x | 2.16x | $-5.91 Million |
| 2018 | -482.70% | -77.24% | 1.50x | 4.16x | $-7.59 Million |
| 2019 | -443.67% | -89.85% | 1.28x | 3.87x | $-7.69 Million |
| 2020 | -45.29% | -134.94% | 0.28x | 1.21x | $-8.96 Million |
| 2021 | -41.66% | -66.17% | 0.52x | 1.21x | $-8.46 Million |
| 2022 | -85.14% | -98.87% | 0.64x | 1.34x | $-9.73 Million |
| 2023 | -86.48% | -70.51% | 0.86x | 1.42x | $-7.73 Million |
| 2024 | -80.81% | -54.62% | 0.88x | 1.68x | $-5.30 Million |
Industry Comparison
This section compares Milestone Scientific's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $1,953,985,100
- Average return on equity (ROE) among peers: -136.95%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Milestone Scientific (MLSS) | $2.55 Million | -47.50% | 2.33x | $20.76 Million |
| Akoya Biosciences Inc (AKYA) | $53.77 Million | -117.77% | 2.35x | $64.44 Million |
| Align Technology Inc (ALGN) | $3.60 Billion | 10.04% | 0.65x | $10.53 Billion |
| AngioDynamics Inc (ANGO) | $37.23 Million | 8.44% | 0.34x | $648.09 Million |
| AptarGroup Inc (ATR) | $313.30 Million | 11.39% | 0.78x | $7.66 Billion |
| AtriCure Inc (ATRC) | $483.76 Million | 10.38% | 0.27x | $2.21 Billion |
| Avinger Inc (AVGR) | $4.24 Million | -1323.46% | 11.63x | $1.52 Million |
| Avantor Inc (AVTR) | $5.57 Billion | -9.53% | 1.12x | $9.19 Billion |
| Azenta Inc (AZTA) | $1.21 Billion | 5.34% | 0.28x | $1.45 Billion |
| Baxter International Inc (BAX) | $2.83 Billion | 11.40% | 1.70x | $12.26 Billion |
| Becton Dickinson and Company (BDX) | $5.43 Billion | 24.24% | 0.78x | $48.93 Billion |
About Milestone Scientific
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that requ… Read more